Figure 1
Figure 1. TFPI improves LTR potential of HSPCs by inhibiting CD26 activity. (A) Progeny of 200 CD45.1 murine KLS cells from cultures with ST with or without TFPI was injected along with 1 × 106 CD45.2 BM cells in lethally irradiated mice. Peripheral blood chimerism derived from CD45.1 cells in primary recipients was analyzed after 3 months (n = 12); 1 × 106 BM cells from primary recipients were injected into lethally irradiated secondary recipient and peripheral blood chimerism from CD45.1 cells was analyzed after 3 months (n = 12). (B) Fifty thousand cells obtained from KLS cells cultured for 5 days with or without TFPI were allowed to migrate through a 3-μm pore-size membrane toward CXCL12 (n = 5). Percentage of cells migrated was assessed. (C) One hundred thousand cells obtained from KLS cells cultured for 5 days with or without TFPI were injected in lethally irradiated hosts (n = 8). The fraction of transplanted Colony forming unit cells that homed into the BM after 16 hours of transplantation was assessed. (D) CD26 activity in KLS cells cultured for 5 days were compared by CD26 enzyme assay (n = 8). Error bars represent SEM. (E) CD26 activity of human UCB derived lin−CD34+, cultured for 2 days with or without TFPI (n = 5). (F) One hundred thousand cells obtained from human lin−CD34+ cells cultured for 2 days with or without TFPI were allowed to migrate through a 3-μm pore-size membrane toward CXCL12 (n = 5). (G) One hundred thousand human lin−CD34+ cells cultured for 2 days with or without TFPI were transplanted in lethally irradiated Rag1−/− preinjected with anti-NK1.1 antibodies. After 16 hours, mice were sacrificed and human HSPCs homed in the BM were quantified by flow cytometric detection of human CD45+lin−CD34+ cells. Total number of HSPCs homed was compared with the number of HSPCs injected and the proportion of homed cells was plotted for different conditions (n = 8, P = .039). Error bars represent SEM; *P < .05; ST, SCF TPO.

TFPI improves LTR potential of HSPCs by inhibiting CD26 activity. (A) Progeny of 200 CD45.1 murine KLS cells from cultures with ST with or without TFPI was injected along with 1 × 106 CD45.2 BM cells in lethally irradiated mice. Peripheral blood chimerism derived from CD45.1 cells in primary recipients was analyzed after 3 months (n = 12); 1 × 106 BM cells from primary recipients were injected into lethally irradiated secondary recipient and peripheral blood chimerism from CD45.1 cells was analyzed after 3 months (n = 12). (B) Fifty thousand cells obtained from KLS cells cultured for 5 days with or without TFPI were allowed to migrate through a 3-μm pore-size membrane toward CXCL12 (n = 5). Percentage of cells migrated was assessed. (C) One hundred thousand cells obtained from KLS cells cultured for 5 days with or without TFPI were injected in lethally irradiated hosts (n = 8). The fraction of transplanted Colony forming unit cells that homed into the BM after 16 hours of transplantation was assessed. (D) CD26 activity in KLS cells cultured for 5 days were compared by CD26 enzyme assay (n = 8). Error bars represent SEM. (E) CD26 activity of human UCB derived linCD34+, cultured for 2 days with or without TFPI (n = 5). (F) One hundred thousand cells obtained from human linCD34+ cells cultured for 2 days with or without TFPI were allowed to migrate through a 3-μm pore-size membrane toward CXCL12 (n = 5). (G) One hundred thousand human linCD34+ cells cultured for 2 days with or without TFPI were transplanted in lethally irradiated Rag1−/− preinjected with anti-NK1.1 antibodies. After 16 hours, mice were sacrificed and human HSPCs homed in the BM were quantified by flow cytometric detection of human CD45+linCD34+ cells. Total number of HSPCs homed was compared with the number of HSPCs injected and the proportion of homed cells was plotted for different conditions (n = 8, P = .039). Error bars represent SEM; *P < .05; ST, SCF TPO.

Close Modal

or Create an Account

Close Modal
Close Modal